|
|
|
| Effect of Jianpi Yifei method in the treatment of stable period in chronic obstructive pulmonary disease |
| KE Jia1 TIAN Fa′nian2 ZHENG Lan1 LI Yong1 |
1.Department of Pulmonary Disease, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province, Wuhan 430074, China;
2.Clinical College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430000, China |
|
|
|
Abstract Objective To study the effect of Jianpi Yifei method in the treatment of stable period in chronic obstructive pulmonary disease (COPD). Methods 116 patients with stable period in COPD admitted to Hubei Provincial Hospital of Traditional Chinese Medicine from October 2017 to September 2018 were divided into control group and treatment group by using random lottery method, 58 cases in each group. After admission, all patients were given basic treatment of western medicine. The treatment group was treated with Jianpi Yifei method on the basis of western medicine. The clinical efficacy, pulmonary function and quality of life before and after treatment were compared between two groups. Results Clinical effect of treatment group was better than that of control group (P < 0.05). After treatment, the FEV1,percentage of FEV1 and FEV1/FVC in two groups were higher than those before treatment (P < 0.05), and treatment group was higher than that control group, the difference was statistically significant (P < 0.05). After treatment, SGRQ scores of two groups were lower than those before treatment (P < 0.05), and treatment group was lower than that control group, the difference was statistically significant (P < 0.05). During the treatment period, no special adverse reactions occurred in both groups. Conclusion Jianpi Yifei method combined with western medicine can improve clinical efficacy of patients with stable period in COPD. It can better improve the quality of life of patients. It is worth popularizing and applying.
|
|
|
|
|
|
[1] Blanchette CMC. Advances in chronic obstructive pulmonary disease among older adults [J]. Curr Opin Pulm Med，2011，17（2）：84-89.
[2] 曾利明.中国40岁以上人群慢阻肺患病率达8.2%[J].上海预防医学，2011，23（8）：408-409.
[3] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2007年修订版）[J].中华结核和呼吸杂志，2007，46（1）：8-17.
[4] 郭振球.实用中医诊断学[M].上海：上海科学技术出版社，2013：117-121.
[5] 朱蕾.临床肺功能[M].北京：人民卫生出版社，2004：1-28.
[6] 彭敏，蔡柏蔷.美国胸科协会和欧洲呼吸协会对慢性阻塞性肺疾病诊治指南的修订[J].中华内科杂志，2005，44（5）：394-397.
[7] Katsura H，Yamada K，Wakabayashi R，et al. The impact of dyspnoea and leg fatigue during exercise on health-related quality of life in patients with COPD [J]. Respirology，2010，10（4）：485-490.
[8] Karpinski NA，Petermann F. COPD：burden，risk factors and prevalence [J]. Gesundheitswesen，2009，71（12）：816.
[9] Barreiro E，Criner GJ. Update in chronic obstructive pulmonary disease 2013 [J]. Am J Respir Crit Care Med，2013， 188（1）：29-34.
[10] 梁剑凌，谢民栋，朱霞.健脾益肺法治疗肺脾气虚型COPD急性加重期患者初探[J].中国当代医药，2012，19（32）：122-123.
[11] 黄淑杰.健脾益肺疗法治疗脾肺气虚型COPD稳定期60例临床分析[J].首都食品与医药，2015，22（12）：72-73.
[12] 湛韬，戴幸平.张锡纯“大气论”对慢性阻塞性肺疾病诊治的启示[J].中医药导报，2016（19）：107-108.
[13] 郭璐璐，王济梅，董晓云.王有奎治疗肺胀经验浅谈[J].中医药导报，2017（4）：118-120.
[14] 杨丽.“培土生金”法之探讨[J].中国中医基础医学杂志，2011，17（10）：1074-1075.
[15] 俞茹云，胡瑶，陈宝华，等.黄芪对慢性阻塞性肺疾病急性加重期患者细胞因子的影响[J].重庆医学，2018，47（28）：115-116，118.
[16] 彭静，陈静，田守征.黄芪白术配伍干预慢性阻塞性肺疾病气道重塑的实验研究[J].河北中医，2018，40（9）：1379-1383.
[17] 李现金，陶有为，张会娜.黄芪党参方联合西药对心脾两虚型缺铁性贫血患者红细胞免疫功能的影响[J].当代医学，2017，23（23）：99-101.
[18] Paap MCS，Lange L，Palen JVD，et al. Using the three-step test interview to understand how patients perceive the St. George′s respiratory questionnaire for COPD patients （SGRQ-C） [J]. Qual Life Res，2016，25（6）：1561-1570.
[19] 李静芬，田景炜，陈瑞，等.圣乔治呼吸问卷对慢性阻塞性肺疾病患者生活质量的调查[J].现代生物医学进展，2016，16（36）：7091-7094.
[20] 谢民栋，梁剑凌，朱霞.健脾益肺法对肺脾气虚型慢性阻塞性肺疾病呼吸肌疲劳的疗效观察[J].中国医药导报，2013，10（21）：115-116，122. |
|
|
|
